Baseimmune
Startup
Baseimmune is a discovery stage biotech company developing universal vaccines with future-proof antigens. The technology is based on a proprietary deep learning platform that models pathogen evolution and immune responses to generate artificial antigens compatible with any delivery systems such as mRNA, viral vectors, and nanoparticles. Founded by a team that pioneered computational approaches to design vaccines against infectious diseases while at the Jenner Institute University of Oxford, with two multi-strain coverage vaccines currently in clinical trials. Baseimmune is now leveraging its next-generation technology to generate longer lasting and mutation-proof antigens that can be applied to highly complex, rapidly mutating pathogens, and emerging pathogens. After raising £4.5M in late 2021, Baseimmune is now focused on the pre-clinical development of a number of universal mutation-proof human and veterinary vaccines including Malaria, Coronavirus and African Swine Fever. Baseimmune is also open to partnering on the design and development of novel indications
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events